 About Validus Pharmaceuticals, Inc. Validus is focused on acquiring, reformulating and marketing prescription products relevant to the psychiatry and neurology markets. Validus seeks to acquire mature products that have well defined and accepted clinical utility relevant to today’s practice of medicine. Validus’ portfolio currently includes Marplan®, which is indicated for the treatment of depression. Marplan is a member of the monoamine oxidase inhibitor class of antidepressants.
Please click below for more information about: |
CONTACT US
Customer Care Center 866-9VALIDUS
Headquarters
Validus Pharmaceuticals, Inc. |